These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 33385764)

  • 1. Occipital gamma-aminobutyric acid and glutamate-glutamine alterations in major depressive disorder: An mrs study and meta-analysis.
    Truong V; Cheng PZ; Lee HC; Lane TJ; Hsu TY; Duncan NW
    Psychiatry Res Neuroimaging; 2021 Feb; 308():111238. PubMed ID: 33385764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis.
    Godfrey KEM; Gardner AC; Kwon S; Chea W; Muthukumaraswamy SD
    J Psychiatr Res; 2018 Oct; 105():33-44. PubMed ID: 30144668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced prefrontal glutamate/glutamine and gamma-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy.
    Hasler G; van der Veen JW; Tumonis T; Meyers N; Shen J; Drevets WC
    Arch Gen Psychiatry; 2007 Feb; 64(2):193-200. PubMed ID: 17283286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Prefrontal γ-Aminobutyric Acid and Glutamate Levels in Individuals With Major Depressive Disorder Using Proton Magnetic Resonance Spectroscopy.
    Ritter C; Buchmann A; Müller ST; Volleberg M; Haynes M; Ghisleni C; Noeske R; Tuura R; Hasler G
    JAMA Psychiatry; 2022 Dec; 79(12):1209-1216. PubMed ID: 36260322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ventromedial prefrontal cortex/anterior cingulate cortex Glx, glutamate, and GABA levels in medication-free major depressive disorder.
    Kantrowitz JT; Dong Z; Milak MS; Rashid R; Kegeles LS; Javitt DC; Lieberman JA; John Mann J
    Transl Psychiatry; 2021 Aug; 11(1):419. PubMed ID: 34354048
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elevated prefrontal cortex γ-aminobutyric acid and glutamate-glutamine levels in schizophrenia measured in vivo with proton magnetic resonance spectroscopy.
    Kegeles LS; Mao X; Stanford AD; Girgis R; Ojeil N; Xu X; Gil R; Slifstein M; Abi-Dargham A; Lisanby SH; Shungu DC
    Arch Gen Psychiatry; 2012 May; 69(5):449-59. PubMed ID: 22213769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excitatory and inhibitory responses in the brain to experimental pain: A systematic review of MR spectroscopy studies.
    Archibald J; MacMillan EL; Enzler A; Jutzeler CR; Schweinhardt P; Kramer JLK
    Neuroimage; 2020 Jul; 215():116794. PubMed ID: 32278899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder.
    Price RB; Shungu DC; Mao X; Nestadt P; Kelly C; Collins KA; Murrough JW; Charney DS; Mathew SJ
    Biol Psychiatry; 2009 May; 65(9):792-800. PubMed ID: 19058788
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subtype-specific alterations of gamma-aminobutyric acid and glutamate in patients with major depression.
    Sanacora G; Gueorguieva R; Epperson CN; Wu YT; Appel M; Rothman DL; Krystal JH; Mason GF
    Arch Gen Psychiatry; 2004 Jul; 61(7):705-13. PubMed ID: 15237082
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Altered neuronal spontaneous activity correlates with glutamate concentration in medial prefrontal cortex of major depressed females: An fMRI-MRS study.
    Zhang X; Tang Y; Maletic-Savatic M; Sheng J; Zhang X; Zhu Y; Zhang T; Wang J; Tong S; Wang J; Li Y
    J Affect Disord; 2016 Sep; 201():153-61. PubMed ID: 27235818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medial prefrontal cortex neurotransmitter abnormalities in posttraumatic stress disorder with and without comorbidity to major depression.
    Swanberg KM; Prinsen H; Averill CL; Campos L; Kurada AV; Krystal JH; Petrakis IL; Averill LA; Rothman DL; Abdallah CG; Juchem C
    NMR Biomed; 2024 Nov; 37(11):e5220. PubMed ID: 39054694
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Region and state specific glutamate downregulation in major depressive disorder: a meta-analysis of (1)H-MRS findings.
    Luykx JJ; Laban KG; van den Heuvel MP; Boks MP; Mandl RC; Kahn RS; Bakker SC
    Neurosci Biobehav Rev; 2012 Jan; 36(1):198-205. PubMed ID: 21672551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An investigation of amino-acid neurotransmitters as potential predictors of clinical improvement to ketamine in depression.
    Salvadore G; van der Veen JW; Zhang Y; Marenco S; Machado-Vieira R; Baumann J; Ibrahim LA; Luckenbaugh DA; Shen J; Drevets WC; Zarate CA
    Int J Neuropsychopharmacol; 2012 Sep; 15(8):1063-72. PubMed ID: 22040773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of rTMS on GABA and glutamate levels in treatment-resistant depression: An MR spectroscopy study.
    Godfrey KEM; Muthukumaraswamy SD; Stinear CM; Hoeh N
    Psychiatry Res Neuroimaging; 2021 Nov; 317():111377. PubMed ID: 34479176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gamma-aminobutyric acid and glutamate/glutamine levels in the dentate nucleus and periaqueductal gray in new daily persistent headache: a magnetic resonance spectroscopy study.
    Chen T; Bai X; Wang W; Zhang X; Pei X; Zhang X; Yuan Z; Zhao Y; Yang Q; Wang Y; Sui B
    J Headache Pain; 2024 Aug; 25(1):142. PubMed ID: 39210271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of Relationship of Ketamine Dose With Magnetic Resonance Spectroscopy of Glx and GABA Responses in Adults With Major Depression: A Randomized Clinical Trial.
    Milak MS; Rashid R; Dong Z; Kegeles LS; Grunebaum MF; Ogden RT; Lin X; Mulhern ST; Suckow RF; Cooper TB; Keilp JG; Mao X; Shungu DC; Mann JJ
    JAMA Netw Open; 2020 Aug; 3(8):e2013211. PubMed ID: 32785636
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does the change in glutamate to GABA ratio correlate with change in depression severity? A randomized, double-blind clinical trial.
    Narayan GA; Hill KR; Wengler K; He X; Wang J; Yang J; Parsey RV; DeLorenzo C
    Mol Psychiatry; 2022 Sep; 27(9):3833-3841. PubMed ID: 35982258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated prefrontal cortex GABA in patients with major depressive disorder after TMS treatment measured with proton magnetic resonance spectroscopy.
    Dubin MJ; Mao X; Banerjee S; Goodman Z; Lapidus KA; Kang G; Liston C; Shungu DC
    J Psychiatry Neurosci; 2016 Apr; 41(3):E37-45. PubMed ID: 26900793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. On the relationship between GABA+ and glutamate across the brain.
    Rideaux R; Ehrhardt SE; Wards Y; Filmer HL; Jin J; Deelchand DK; Marjańska M; Mattingley JB; Dux PE
    Neuroimage; 2022 Aug; 257():119273. PubMed ID: 35526748
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentrations of Cortical GABA and Glutamate in Young Adults With Autism Spectrum Disorder.
    Kolodny T; Schallmo MP; Gerdts J; Edden RAE; Bernier RA; Murray SO
    Autism Res; 2020 Jul; 13(7):1111-1129. PubMed ID: 32297709
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.